Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. CRASH-2 collaborators, et al. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X. Lancet. 2011. PMID: 21439633 Clinical Trial.
Disseminated BCG Disease in a Child with a Novel PSMG2 Deletion.
Bernacchia A, Garcia AL; Autoinflammatory Disease Consortium; Raccio AG, Di Giovanni D. Bernacchia A, et al. Among authors: garcia al. J Clin Immunol. 2024 Jun 7;44(6):145. doi: 10.1007/s10875-024-01738-1. J Clin Immunol. 2024. PMID: 38847935 No abstract available.
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
Gonzalez-Lopez TJ Dr, Bermejo N, Cardesa-Cabrera R, Martínez V, Aguilar-Monserrate G, Pérez Segura G, García AD, Luis-Navarro J, Lakhwani S, Acedo N, Lozano ML, Bernat S, Torres-Tienza A, Ruano A, Jarque I, Galán Alvarez P, Benet Campos C, Marcellini-Antonio S, Jimenez-Bárcenas R, Martínez-Carballeira D, de Miguel Llorente D, Perona Blázquez Á, González-Gascón-Y-Marín I, Lopez-Ansoar E, Alonso Alonso JM, Bengochea-Casado ML, Díaz Gálvez FJ, Moretó A, Moreno G, Hernández-Martin R, de Cabo E, Davila-Valls J, Cuesta A, Pastoriza Cruz C, Hermida G, García C, Pozas-Mañas MA, Aguilar-Franco C, Fernandez-Jimenez D, Navas-Elorza B, López-Santamaría Castro C, Lorenzo Vizcaya A, Ortín X, Pintos MG, Piernas S, Díaz-Santa J, Soto-Ortega I Dr, Provan D, García-Donas Gabaldón G. Gonzalez-Lopez TJ Dr, et al. Among authors: garcia ad. Blood. 2024 Jun 6:blood.2024024250. doi: 10.1182/blood.2024024250. Online ahead of print. Blood. 2024. PMID: 38843478
Corrigendum to: An account on the history of pharmacology in Spain [Pharmacol. Res. 202 (2024) 107104 Pages 1-11 https://doi.org/10.1016/j.phrs.2024.107104].
Aldea-Perona AM, Beledo JF, Frías Iniesta J, García AG, Tamargo J, Zaragozá F. Aldea-Perona AM, et al. Among authors: garcia ag. Pharmacol Res. 2024 May 30:107240. doi: 10.1016/j.phrs.2024.107240. Online ahead of print. Pharmacol Res. 2024. PMID: 38821766 Free article. No abstract available.
8,251 results